WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2010112538) A MULTIPART FLUID SYSTEM AND A SYSTEM FOR REGIONAL CITRATE ANTICOAGULATION IN AN EXTRACORPOREAL BLOOD CIRCUIT
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2010/112538    International Application No.:    PCT/EP2010/054267
Publication Date: 07.10.2010 International Filing Date: 31.03.2010
IPC:
A61K 33/06 (2006.01), A61K 31/191 (2006.01), A61K 31/194 (2006.01), A61K 31/7004 (2006.01), A61K 33/10 (2006.01), A61K 33/14 (2006.01), A61K 33/20 (2006.01), A61K 33/42 (2006.01), A61P 7/08 (2006.01)
Applicants: GAMBRO LUNDIA AB [SE/SE]; P.O. Box 10101 S-220 10 Lund (SE) (For All Designated States Except US).
STERNBY, Jan [SE/SE]; (SE) (For US Only)
Inventors: STERNBY, Jan; (SE)
Agent: AHLBERG, Camilla; P.O. Box 10101 S-220 10 Lund (SE)
Priority Data:
0900422-7 31.03.2009 SE
61/164,922 31.03.2009 US
Title (EN) A MULTIPART FLUID SYSTEM AND A SYSTEM FOR REGIONAL CITRATE ANTICOAGULATION IN AN EXTRACORPOREAL BLOOD CIRCUIT
(FR) CIRCUIT DE FLUIDES À PLUSIEURS PARTIES ET SYSTÈME D'ANTICOAGULATION LOCALE À BASE DE CITRATE DANS UN CIRCUIT EXTRACORPOREL
Abstract: front page image
(EN)The present invention concerns a multipart fluid system for use in CRRT, wherein the multipart fluid system comprises an anticoagulation fluid and at least one fluid from the group consisting of a dialysis fluid and an infusion fluid. According to the invention the anticoagulation fluid comprises at least 8 mM citrate, and the dialysis fluid and/or infusion fluid comprises 2-8 mM citrate and 1-5 mM total calcium. The present invention further concerns a system for regional citrate anticoagulation in an extracorporeal blood circuit.
(FR)Cette invention concerne un circuit de fluides à plusieurs parties utilisé en suppléance rénale [épuration extrarénale continue (EERC) ou continuous renal replacement therapy (CRRT)], ledit circuit de fluides à plusieurs parties comprenant un fluide anticoagulant et au moins un fluide choisi dans le groupe constitué par une solution de dialyse et un liquide de perfusion. Selon l'invention, le fluide anticoagulant comprend au moins 8 mM de citrate, et la solution de dialyse et/ou le liquide de perfusion comprend 2 à 8 mM de citrate et 1 à 5 mM de calcium total. L'invention concerne par ailleurs un système d'anticoagulation locale à base de citrate dans un circuit extracorporel.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)